Pluton Biosciences

Pluton Biosciences

Early Stage

Unearthing world-changing solutions.

Unearthing world-changing solutions.

Overview

Raised to Date: Raised: $6,682,968

Logos provided by Clearbit
Platform

Self Managed

Start Date

09/16/2021

Close Date

09/30/2021

Min. Goal
$10,344
Max. Goal
$6,682,968
Min. Investment

$10,344

Security Type

Equity - Common

SEC Filing Type

RegD 506(b)    Open SEC Filing

Logos provided by Clearbit
Status
Funded
Reporting Date

09/29/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$514,074

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Logos provided by Clearbit
Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Company Website

Pluton Biosciences is raising funds independently through Reg D 506(b) raise. The company is using its innovative process to realize the potential of undiscovered microbes. The Microgaming Innovation Engine of Pluton Biosciences makes the discovery of novel microbes possible and commercially viable. Pluton Biosciences is discovering the next-generation products for carbon sequestration, agriculture, biomaterials, and bioremediation. Charlie Walch and Barry Goldman founded Pluton Biosciences in January 2017. The current crowdfunding campaign has a maximum target of $6.68 million. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Pluton Biosciences 09/29/2021 Self Managed - $6,682,968 Equity - Common Funded RegD 506(b)
Pluton Biosciences 06/06/2019 Nvsted - $98,000 Debt Funded RegCF
Pluton Biosciences 01/01/2019 Self Managed - - Debt Funded RegD 506(c)
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Pluton Biosciences on Self Managed 2021
Platform: Self Managed
Security Type: Equity - Common

Follow company

Follow Pluton Biosciences on Self Managed 2021
Deal Analytics
Deal Considerations

Buy Pluton Biosciences's Deal Report

Warning: according to the close date for this deal, Pluton Biosciences may no longer be accepting investments.

Pluton Biosciences Deal Report

Get KingsCrowd’s comprehensive report on Pluton Biosciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Pluton Biosciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Pluton Biosciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge